Polyrizon Ltd
PLRZ12.845USD
+0.400+3.22%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
12.59MMarket Cap
LossP/E TTM
More Details of Polyrizon Ltd Company
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
Polyrizon Ltd Info
Ticker SymbolPLRZ
Company namePolyrizon Ltd
IPO dateOct 29, 2024
CEOIzraeli (Tomer)
Number of employees1
Security typeOrdinary Share
Fiscal year-endOct 29
AddressHaTidhar St. 5
CityRA'ANANA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code- -
Phone97293740120
Websitehttps://polyrizon-biotech.com/
Ticker SymbolPLRZ
IPO dateOct 29, 2024
CEOIzraeli (Tomer)
Company Executives of Polyrizon Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Tomer Izraeli
Mr. Tomer Izraeli
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
--
Mr. Nir Ben Yosef
Mr. Nir Ben Yosef
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Eyal S. Ron, Ph.D.
Dr. Eyal S. Ron, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Dr. Tidhar Turgeman
Dr. Tidhar Turgeman
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Daphna Avital
Ms. Daphna Avital
Chief People Officer
Chief People Officer
--
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Director
Director
--
--
Mr. Omer Srugo
Mr. Omer Srugo
Independent Director
Independent Director
--
--
Ms. Liat Sidi
Ms. Liat Sidi
Independent Director
Independent Director
--
--
Mr. Yehonatan Zalman Vinokur
Mr. Yehonatan Zalman Vinokur
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Tomer Izraeli
Mr. Tomer Izraeli
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
--
Mr. Nir Ben Yosef
Mr. Nir Ben Yosef
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Eyal S. Ron, Ph.D.
Dr. Eyal S. Ron, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Dr. Tidhar Turgeman
Dr. Tidhar Turgeman
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Daphna Avital
Ms. Daphna Avital
Chief People Officer
Chief People Officer
--
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Wed, Dec 17
Updated: Wed, Dec 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
L.I.A. Pure Capital Ltd
9.99%
Eli (Zamir)
9.99%
UBS Financial Services, Inc.
0.06%
Other
79.96%
Shareholders
Shareholders
Proportion
L.I.A. Pure Capital Ltd
9.99%
Eli (Zamir)
9.99%
UBS Financial Services, Inc.
0.06%
Other
79.96%
Shareholder Types
Shareholders
Proportion
Individual Investor
10.00%
Corporation
9.99%
Investment Advisor
0.06%
Other
79.95%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
10
1.04K
0.07%
-57.85K
2025Q3
10
370.57K
6.19%
+370.41K
2025Q2
15
715.00
0.01%
-142.00
2025Q1
18
1.04K
18.49%
+190.00
2024Q4
14
2.89M
68.88%
+2.89M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
L.I.A. Pure Capital Ltd
159.24K
9.99%
+159.22K
+1592250.00%
Dec 05, 2025
Eli (Zamir)
159.24K
9.99%
+159.24K
--
Dec 05, 2025
UBS Financial Services, Inc.
2.04K
0.13%
-2.89K
-58.54%
Sep 30, 2025
Srugo (Raul)
21.00
0%
-2.00
-8.70%
Mar 10, 2025
Srugo (Itzhak)
20.00
0%
-3.00
-13.04%
Mar 10, 2025
Srugo (Yoav)
19.00
0%
-4.00
-17.39%
Mar 10, 2025
Srugo (Sofi Yochelman)
19.00
0%
--
--
Mar 10, 2025
Citi Investment Research (US)
19.00
0%
-66.00
-77.65%
Sep 30, 2025
Izraeli (Tomer)
8.00
0%
--
--
Mar 10, 2025
Scisparc
--
0%
-21.00
-100.00%
Mar 10, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
May 22, 2025
Merger
250→1
Date
Ex-dividend Date
Type
Ratio
May 22, 2025
Merger
250→1
